StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Intangible Asset Amortization Expense by Quarter

Intangible Asset Amortization Expense ($M) ($M)

QuarterlyAnnual

Amgen Intangible Asset Amortization Expense: $890M in Q2 2026, down 19.1% from a year earlier.

Latest, Q2 2026
890
Period ended Jun 30, 2026
Change on a year earlier
-19.1%
1,100 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
36
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Goodwill and Other Intangible Assets Note (XBRL).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntangible Asset Amortization Expense ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026890-19.1%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026896-25.3%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 2025900-25.0%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20251,100-8.3%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20251,100-8.3%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20251,2000.0%Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 20241,200+9.1%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20241,200+73.2%Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 20241,200+73.2%Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 20241,200+73.2%Form 10-Q (filed 2025-05-02) ↗
Q4 2023Dec 31, 20231,100+57.1%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 2023693+10.4%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 2023693+10.2%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023693+8.8%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 20227000.0%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 2022628-2.2%Form 10-Q (filed 2023-10-31) ↗

Breakdown

What makes up intangible Asset Amortization Expense

Cite this data

StockData. (2026). Amgen Intangible Asset Amortization Expense ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/intang-amort-exp

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.